Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This Article MAY explain why the temporary dip in our share price....https://www.fool.com.au/2018/06/20/is-this-why-the-auscann-group-holdings-ltd-asxac8-share-price-fell-14/
It Would Seem We dodged a bullit by going Slow and Steady....Buckle up, California consumers: It’s going to be a wild summer. Industry watchers are expecting to see statewide bargain blowout sales over the next two weeks, followed by immediate product shortages and price spikes.
The cause of the turmoil is the state’s fast-approaching testing and packaging deadline. As of July 1, 2018, all licensed medical and adult-use cannabis must conform to the state’s new testing and packaging requirements, to insure products are clean and child-resistant.
Look out for deals in email newsletters, social feeds and websites. You may find savings of 30% to 90% on flower, edibles, and extracts, with price reductions peaking at the end of June.
June blowouts will be better than Christmas, New Year’s, 4/20 or Memorial Day, said Erick Alfaro, operations manager for The Green Cross, an adult-use retail store in San Francisco. “This would be the best month for anybody trying to save some money and buy any type of cannabis.”
A few examples:
San Francisco storefront The Green Cross started blowing out flowers and edibles at 30% off in late May.
Buds & Roses customers in Los Angeles can expect to save 30% to 50% or more on rare products like cannabis oil in syringe applicators, as well as suppositories, both of which are in non-compliant packaging as of July 1.
Delivery service Sava emailed 75% off deals on flowers.
Connected Cannabis Co. dumped last year’s outdoor Gelato #41 for $40 per half-ounce at the June 3 Cannabis Cup in Santa Rosa.
Super-strong edibles of more than 100 milligrams are going to become a collector’s item, said Stephen Rechif, operations manager at The Bloom Room shop in San Francisco.
“Find any Kushy Punch TKOs,” he said. “Those are going extinct.”
What follows after July 1 is anyone’s guess. New brands might become statewide staples, while some legendary brands will be out of the marketplace, said edibles maker Kenny Morrison of Venice Cookie Co., and head of the California Cannabis Manufacturer’s Association. “It’s definitely a reckoning,” Morrison said. “We’re transitioning as we speak.”
You can see the below on Equity.guru...
Livestream: Chris Parry rants to MidasLetter’s James West about MedMen, as company pulls plug on bonuses
Some News.... AusCann Group Holdings Limited (ASX:AC8)
AusCann’s Chilean JV DayaCann has completed its second harvest The harvest yielded 620kg of dried cannabis buds, an increase from last year’s crop The yield will be used for Chilean patients and potential export Patients in Chile’s new special access scheme are being supplied DayaCann cannabis AusCann sees significant potential in the South American market following recent regulatory changes in the region
Thursday 07 June 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) is pleased to announce that it has completed its second harvest with DayaCann joint venture partner Fundación Daya in Chile. The second crop yielded 620kg of dried cannabis product, an increase of over 50 per cent on the 400kg yielded from the first crop. This equates to an approximate yield of 1.2 tonnes per Hectare.
READ THE ARTICLE BELOW.
READ EQUITY ARTICLE BELOW.
I'm in this week, but not on the 29th, too frothy. Good company plan with their own grow, excellent locations. Stopped by their NYC store on 5th Ave. Most impressive. GLTA...
Thanks for the info, looks like a promising company. All ready established, grows its own, and sells its own, no middle man.
This just keeps getting better. Good hook up with 420....If you’d like to try Tinley for yourself and count yourself a California, Santa Ana’s 420 Central is offering home delivery of Tinley this Memorial Day weekend to specific LA and OC neighborhoods.
Slow but steady growth and progress.
And The News Keeps Getting Better......SMITHS FALLS, ON and MELBOURNE, Australia, April 25, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is pleased to join the Victoria State Government in announcing the launch of the newest member of the Canopy Growth family, Spectrum Cannabis Australia ("Spectrum" or "Spectrum Australia").
Logo: Spectrum Cannabis (CNW Group/Canopy Growth Corporation)
Minister for Agriculture, the Hon. Jaala Pulford, alongside Ben Quirin, Managing Director of Spectrum Australia, announced the Company will invest up to $16 million AUD (~$16 million CAD) in the State of Victoria over the next four years to establish Spectrum's Asia-Pacific (APAC) headquarters and research and development facility.
"The State Government of Victoria has been an outstanding partner and welcomed our investment in the region with a shared passion for innovation in the medical cannabis industry," said Ben Quirin, Managing Director, Spectrum Australia. "Victoria is now home for Spectrum as we introduce our world renowned medical cannabis products to the State, across Australia, and throughout the entire APAC region as jurisdictions establish legal, regulated medical cannabis regimes."
The Victoria facility will enable domestic cultivation and production of high quality medical cannabis for patients while serving as a distribution hub for other jurisdictions in APAC. It will also operate as the APAC Research and Development Center for the Company, supporting the ongoing research collaboration between Spectrum Australia and Agriculture Victoria on innovations in medical cannabis cultivation and production.
"Collaborating with international experts on cultivation and manufacturing will build Victoria's capacity to develop our medicinal cannabis industry to be able to supply reliable and high quality medicinal cannabis products," said Minister for Agriculture, the Hon. Jaala Pulford.
The launch of Spectrum Australia builds on Canopy Growth's leadership position in the global medical cannabis space. Spectrum Australia's priority is to improve the lives of patients. This goal will be accomplished by focusing on three core areas:
Ensuring an affordable and consistent supply of medical cannabis is available to patients in Australia
Building production and research infrastructure in Australia
Engaging in rigorous evidence-based physician and pharmacist education to ensure patients' access needs are met
This week Canopy Growth renewed its commitment to Australian partner, AusCann (ASX:AC8). Together with the State Government of Victoria and our strong local partner Spectrum Australia is committed to building an industry for the benefit of patients and healthcare professionals throughout APAC.
This Should Help Move Things Along....AusCann Group Holdings Limited (ASX:AC8)
ASX Announcement | 24 April 2018
Highlights
AusCann and Canopy are working to become the leading suppliers of medical cannabis products to the Australian market AusCann and Canopy are proposing to enter into a supply arrangement, which will see AusCann distributing products through an expanded network and developing an expanded pipeline covering multiple disease areas AusCann to scale up its existing medical liaison team and building an independent clinic network of allied partners to educate doctors about the products
F.Y.I. A NY Times article.https://www.nytimes.com/2018/04/17/world/australia/marijuana-legalize.html
Well, This Should Help...The Washington Post has broken news that could be the most important political change for the cannabis industry to date, suggesting that Senator Cory Gardner (R: CO) has struck a deal with President Trump regarding the rights of states to regulate cannabis. While there is no final deal, the Senator, who has been blocking Department of Justice nominations, suggest that his discussions with other senators will yield a bill that would permanently address the issue of federal enforcement.
Slow and Steady. Delivering on their promises...
YES..AT LAST..The Tinley Beverage Company Inc. (the “Company" or "Tinley") (CSE:TNY) (OTCQX:TNYBF) (formerly OTC:QRSRF) is pleased to announce that it has produced an initial batch of its TinleyTM Cocktails cannabis margarita. Tinley is also pleased to announce that a leading licensed distributor has agreed in principle to carry Tinley cannabis-infused products throughout California, and it is working towards a definitive distribution agreement in time for the anticipated release of the product
Informative Article in Equity.guru Today on our Company. Sitting down with Tinley Beverage (TNY.C) boss Jeff Maser – and some damn fine bottles
://www.fool.com.au/2018/03/01/why-i-own-shares-in-pot-stock-auscann-group-holdings-ltd/
THE MASTER PLAN IS COMING TOGETHER... The Company also plans to launch an integrated marketing program with its upcoming Tinley™ ’27 cannabis products.
??????? The Company intends to use the net proceeds from the Offering for expansion beyond California, beverage marketing, acquisitions, and working capital. ANY IDEAS ON WHERE and WHO??????
AND WE KEEP GROWING...Tinley Announces $10,000,000 Brokered Private Placement Co-Led by Canaccord Genuity and Gravitas Securities
Good news this morning!!!????
All the necessary steps for production/distribution & profitability are in place. SANTA MONICA, Calif. and TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") is pleased to announce that it has entered into a lease agreement for a 20,000 square foot facility in Long Beach, California for cannabis beverage production. The Company is also pleased to announce that its temporary facility in Riverside County, California has successfully completed all remaining inspections required for cannabis operations, and it has accordingly received a Certificate of Occupancy.
GOOD NEWS...SANTA MONICA, Calif. and TORONTO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") (CSE:TNY) (OTC:QRSRF) is pleased to announce that its intended Phase I cannabis production facility has completed its municipal cannabis inspection for cannabis manufacturing.
Increased cash position AND they may be producing for the Cali market soon in their own building!!! Tinley Completes Facility Retrofits and Provides Corporate Update
January 23, 2018 12:54 ET | Source: The Tinley Beverage Company Inc.
THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. PERSONS.
SANTA MONICA, Calif. and TORONTO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") (CSE:TNY)(OTC:QRSRF) is pleased to provide an update to the market on the progress of executing on its business plan.
Tinley ’27 Cannabis Drinks Launch
The Company has been engaged in a search for a facility in California to house its Phase I bottling line. The Phase I Bottling Facility will be used to produce and bottle its line of THC infused beverages, Tinley ’27 and Tinley Cocktails, until the Company completes a build of its long-term, full-scale bottling plant. The Phase I facility will also be used to provide co-packing services for third-party beverage producers. Tinley has identified a facility in Riverside County, California, and this facility has now completed retrofits requested by the municipality, including those requested by Tinley to accommodate Tinley’s bottling equipment. The facility is awaiting what it believes to be its final municipal inspection to allow production of various products, including Tinley’s beverages. The Company has agreed, in principle, to all material terms to house the Phase I bottling equipment and intends to enter a binding agreement with the facility, contingent upon it receiving its permit. At such time, Tinley intends to commence immediate filling operations, and expects production of the initial products to take 2-3 weeks to complete. Initial products include the Tinley Margarita and the Tinley ’27 Coconut Rum.
Increased Cash Position
The Company currently has approximately $4.6 million in cash and liquid securities, representing an increase of approximately $800,000 from the total accessible cash of approximately $3.8 million reported in the Company’s last quarterly release on September 30, 2017. The Company feels this is sufficient capital for producing the Tinley ’27 batches planned for its temporary facility, bringing its long-term bottling facility into operation, marketing and working capital.
AUSCANN ENTERS INTO HEADS OF AGREEMENT WITH AUSTRALIA'S LEADING WHOLESALE DISTRIBUTOR
AusCann is pleased to announce it has entered into a Heads of Agreement (HoA) with ASX listed Australian Pharmaceutical Industries Limited (ASX:API) to form a wholesale agreement for the distribution of AusCann's cannabinoid medicines throughout Australia.
The collaboration between AusCann and API aligns the competencies of AusCann and its expertise in the medical cannabis industry and Australia's leading wholesale distributor of pharmaceutical products. This agreement will help establish strong distribution channels for the supply of AusCann's medications to Australian patients.
As part of the wholesale agreement, AusCann will distribute imported cannabinoid medicines from its Canadian partner, Canopy Growth Corporation, ahead of establishing its own local supply of medications. AusCann is working closely with its strategic partner Tasmanian Alkaloids in establishing its cultivation and manufacturing operations in Tasmania, with the first crop expected to be planted this year.
January 19, 2018
15 Companies Take 10% of Initial California Cannabis Licenses
Published by NCV Newswire
Trends and Surprises From California’s First 1,000 Cannabis Licenses
Guest post by Ed Keating, Co-Founder and Chief Data Officer at Cannabiz Media
We’re not even a month into recreational marijuana sales in California, and already, the state has been issuing 50 marijuana licenses per day. The team at Cannabiz Media has been tracking these licenses closely, and with thousands of licenses still pending in the state’s queue, the team believes this license pace will continue well into the future.
Based on research from the Cannabiz Media License Database, let’s take a closer look at some of the most interesting trends developing in California.
Most Early Cannabis Licenses are Going to Cultivators, Dispensaries, Retailers, and Manufacturers
We all know how big the California market is (it’s the sixth largest economy in the world), so it’s not surprising that a large number of marijuana licenses have already been awarded across the value chain. For a bit of background, it helps to understand how the California regulatory structure works when it comes to issuing licenses:
Department of Food and Agriculture: Licenses cultivators of both medical and recreational marijuana.
Department of Public Health: Licenses manufacturers of cannabis-infused edibles for medical and recreational use.
Bureau of Cannabis Control: Licenses retailers, distributors, testing labs, and microbusinesses.
As of January 15, 2018, the Bureau of Cannabis Control (BCC) had issued 622 licenses compared to 349 issued by the Department of Food and Agriculture (DOFA) and 302 by the Department of Public Health (DOH). You can see the breakdown by issuing department in the chart below.
Diving a bit deeper into the data, the Cannabiz Media License Database reveals that a total of 1,273 cannabis licenses have been issued in California. The breakdown by license type follows:
Cultivator = 322 licenses (27% of all licenses)
Dispensary/retailer = 322 licenses (25% of all licenses)
Manufacturer = 302 licenses (24% of all licenses)
Distributor = 176 licenses (14% of all licenses)
Microbusiness = 57 licenses (4% of all licenses)
Delivery = 52 licenses (4% of all licenses)
Testing = 15 licenses (1% of all licenses)
You can see this data in the chart below.
15 Companies Hold 10% of All Cannabis Licenses in California
Marijuana was legalized in California long ago, so there are companies doing business in the state that have already established brands and expert management. As a result, some of these companies are early winners of many licenses. In fact, just 15 companies hold nearly 10% of the 1,273 licenses awarded as of January 15, 2018 in California. Here’s the leader board to date:
Honeydew Farms LLC = 29 licenses
Harborside = 12 licenses
KindPeoples = 12 licenses
CA Systematize = 8 licenses
Airfield Supply Co. = 6 licenses
CALIVA = 6 licenses
ECD, Inc. = 6 licenses
P & S Ventures = 6 licenses
Purple Lotus Patient Center = 6 licenses
The Genezen Project = 6 licenses
Theraleaf Relief, Inc. = 6 licenses
Canna Culture Collective, Inc. = 5 licenses
Event Horizon Technologies = 5 licenses
NC3 Systems, INC. = 5 licenses
The Apothecarium = 5 licenses
Of particular interest are license holders who are bundling licenses to create larger sites or stacking licenses by obtaining them from different regulators. For example, CA Systematize obtained its eight licenses from all three issuing agencies, including small medical and adult cultivation licenses, adult and medical extraction licenses, and retailer and dispensary licenses. Suffice it to say, this strategy certainly required a highly effective compliance team who had to coordinate multiple licenses from the three different regulators in a very short timeframe.
Another example is Honeydew Farms, which operates in Humboldt County, California. The company pursued a two-step strategy to compete with large grow sites that had permits with other municipalities. First, it secured conditional use permits in Humboldt County. Second, it applied for and received its 29 small/medium outdoor cultivation licenses bringing it to the top of the California license leaderboard at this time.
Seven Cities Account for 40% of Issued Cannabis Licenses in California
The number of jurisdictions that have received cannabis licenses changes on a daily basis. As of January 15, 2018, cities that passed marijuana ordinances and issued local permits have reaped the early rewards. In total, 162 jurisdictions in California have received licenses, and just seven cities account for 40% of those licenses. Here is a license breakdown by city:
Oakland = 138 licenses (12% of all licenses)
San Jose = 87 licenses (8% of all licenses)
Sacramento = 66 licenses (6% of all licenses)
San Francisco = 49 licenses (4% of all licenses)
Cathedral City = 40 licenses (4% of all licenses)
San Diego = 37 licenses (3% of all licenses)
Arcata = 33 licenses (3% of all licenses)
What’s Next for Cannabis Licenses in California?
As mentioned earlier in this article, Cannabiz Media believes this fast-paced licensing trend will continue for some time. In fact, if the trend continues. There could be more than 10,000 licensed California marijuana businesses by the end of 2018!
What remains to be seen is how market maturity will affect license distribution and the overall California cannabis license landscape in terms of the types of licenses awarded, who holds those licenses, and where the businesses holding those licenses are operating. Cannabiz Media will be tracking it all in the Cannabiz Media Licensing Database, so stay tuned for updates.
About the author:
Ed Keating is a co-founder of Cannabiz Media and oversees our data research and government relations efforts. He has spent his whole career working with and advising information companies in the compliance space. Ed has overseen complex multijurisdictional product lines in the securities, corporate, UCC, safety, environmental and human resource markets and focuses on workflow products. Ed has spent the last twenty five years in the information industry. During that time he has worked for both startup and established information companies where he has led marketing, product management and sales organizations. These companies include Wolters Kluwer/Commerce Clearing House, CT Corporation, EDGAR Online and Business & Legal Reports.
At Cannabiz Media, Ed enjoys the challenge of working with regulators across the country as he and his team gather corporate, financial, and license information to track the people, products and businesses in the cannabis economy. Ed graduated from Hamilton College and received his MBA from the Kellogg School at Northwestern University. He has been active with the Software & Information Industry Association for his whole career and managed the Content Division for six years.
Are you a cannabis industry thought leader and want to be heard? Let us know your story.
Published by NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.
Get Our Sunday Newsletter
email address
Subscribe
In this article:
Airfield Supply Co., CA Systematize, California, CALIVA, Canna Culture Collective, Cannabiz Media, ECD, Event Horizon Technologies, Harborside, Honeydew Farms, Inc, KindPeoples, NC3 Systems, P & S Ventures, Purple Lotus Patient Center, The Apothecarium, The Genezen Project, Theraleaf Relief
Related News:
From today's Equity.guru article 1/3/18
TINLEY BEVERAGE COMPANY (TNY.C) $0.30 –> $1.89
Christ on a bike.
We thought Tinley was crazy when it was around $0.80 a few weeks ago and suggested it might be a good point to take some profits. We hope you ignored us.
Long time readers who bought stock at $0.30 (or even recent readers, as you could have got it for that in October) are wondering what cut of steak to purchase a truckload of at this point.
Tinley is running on hot for several reasons – it’s a California play, smartly, and it’s an alcohol play, smartly, and it’s been talking about releasing its THC cocktail SKUs right about now for a few months.
This stock has been primed for a big spike for 2018 by design, and though we struggle with the $137 million market cap, nobody is looking at market caps in weed anymore.
And any deal with a boozeco will see that share price launch into greater heights.
Well played, Tinley.
CEO Jeff Maser talked to our livestream eight months ago and laid out his whole plan, which he’s achieved in no uncertain terms.
2 hours 49 min ago
After much anticipation, the federal government has finally announced the legalization of cannabinoid-infused foods and beverages in Canada. This announcement included in the approval and release of edits to Bill C-45. Included in the law’s amendments was a deadline stating that edibles (cannabinoid-infused foods and beverages) will be available to the public, alongside the marijuana adult use legalization, set to launch in 2018.
AusCann Group Holdings Ltd (ASX:AC8) through its 50:50 joint venture in Chile, DayaCann, has secured its second cultivation licence for its second medical cannabis crop.
This is the only licence granted in Chile to cultivate medical cannabis and allows the joint venture to commence cultivation activities.
The DayaCann joint venture will commence planting crops immediately at its licensed 30-hectare facility south of Santiago, Chile.
The licence follows the successful harvest of 400 plants earlier this year that provided a range of chemotypes to be used in initial trial formulations.
DayaCann is currently the only licensed producer in Chile, giving it a key competitive advantage in a growing market.
AusCann Group Holdings Ltd (ASX:AC8) has been granted a trading halt by the ASX this morning, pending details regarding the company's Chilean joint venture.
This should help AC8 become profitable.... Aussie cannabis could soon be cleared for export, igniting new revenue streams for ASX-listed medical marijuana plays.
Currently only manufactured cannabis products are allowed to be exported from Australia under tight conditions. Exports of the raw material — the plants — are blocked to ensure Australian businesses and patients have first dibs.
But after the federal Office of Drug Control, prompted by health minister Greg Hunt, found “overwhelming support for allowing the export of medicinal cannabis products” in August, expectations for a policy change are high.
It certainly has been a great week for the Auscann Group Holdings Ltd (ASX: AC8) share price.
In afternoon trade the medicinal cannabis company’s shares are 5% to 51 cents, bringing their week-to-date return to over 29%.
Why are its shares flying high this week?
It isn’t just AusCann which is flying high this week. A good number of its pot stock peers are posting strong gains as well.
The Cann Group Ltd (ASX: CAN) share price is up 15%, Creso Pharma Ltd (ASX: CPH) is 4% higher, Hydroponics Company Ltd (ASX: THC) is a sizeable 20% higher, and MGC Pharmaceuticals Ltd (ASX: MXC) is up 16%.
While MGC Pharmaceuticals is higher due to a supply agreement with a Korean cosmetics company, the others have climbed higher due to developments in North America.
This week it was revealed that Canadian cannabis giant, and one of AusCann’s major shareholders, Canopy Growth Corp has attracted the attention of one of the world’s biggest alcoholic beverage companies.
Constellation Brands, the US$42 billion company behind the Corona beer brand, has agreed to buy a 9.9% stake in Canopy Growth Corp for C$245 million.
According to its press release, Constellation Brands sees the cannabis market as a significant consumer category in the future.
What next?
Other alcoholic beverage companies are tipped to follow Constellation Brands’ lead and gain exposure to the industry also.
It appears as though some traders are speculating that one of Australia’s producers could be a potential target.
While I believe that Canadian producers are more likely to be targeted for geographical reasons and the fact that recreational use will soon be legalised in the country, there is a good chance that Australian growers will benefit from increased demand for produce from the North American market.
This could potentially put some of our local pot stocks in a position to generate revenue sooner than expected. But despite this positive, I still think it is a little too soon to make an investment and suggest investors watch on from the safety of the sidelines.